Encyclopedia

  • Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies
  • Add time:07/17/2019         Source:sciencedirect.com

    Herein, we described the design and synthesis of a series of pyridazine-3-carboxamides to be CB2-selective agonists via a combination of scaffold hopping and bioisosterism strategies. The compounds were subjected to assessment of their potential activities through calcium mobilization assays. Among the tested derivatives, more than half of these compounds exhibited moderate to potent CB2 agonist activity. Six compounds showed EC50 values below 35 nM, and several derivatives also exhibited significantly enhanced potency and high selectivity at the CB2 receptor over the CB1 receptor. Specifically, compound 26 showed the highest CB2 agonist activity (EC50 = 3.665 ± 0.553 nM) and remarkable selectivity (Selectivity Index > 2729) against CB1. In addition, logPs of some representative compounds were measured to display significantly decreased values in comparison with GW842166X. Furthermore, docking simulations were conducted to explain the interaction mode of this series.

    We also recommend Trading Suppliers and Manufacturers of 1-BUTYL-6-OXO-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLIC ACID (cas 103854-71-3). Pls Click Website Link as below: cas 103854-71-3 suppliers


    Prev:Human monocyte differentiation stage affects response to arachidonic acid
    Next: Adsorption of pesticides CARBETAMIDE (cas 16118-49-3) and Metamitron on organohydrotalcite)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View